At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,232 enrolled
Drug / intervention
Digital stethoscope electrocardiogramother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Screening for Peripartum Cardiomyopathies Using Artificial Intelligence (SPEC-AI) in Nigeria
In Brief
A clinical study evaluating Digital stethoscope electrocardiogram for Cardiomyopathy and Pregnancy Related. Completed, enrolled 1,232 participants across 6 sites.
Detailed Summary
This study will evaluate the effectiveness of an artificial intelligence-enabled ECG (AI-ECG) for cardiomyopathy detection in an obstetric population in Nigeria.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiomyopathy, Pregnancy Related
CountriesNigeria
Timeline
N/ACompletedFinished
2023202420252026
First PostedJun 2022
Enrollment StartAug 2022
Primary CompletionMay 2024
TodayJul 2026
First PostedJun 30, 2022
Enrollment StartAug 15, 2022
Primary CompletionMay 15, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.0 years ago
Interventions
Digital stethoscope electrocardiogramother
Digital stethoscope artificial intelligence enabled electrocardiogram (AI-ECG). An artificial intelligence algorithm which analyses ECG data and generates prediction probabilities for a diagnosis of cardiomyopathy.